Lv1
20 积分 2024-08-16 加入
Improving Dose-Optimization Processes Used in Oncology Drug Development to Minimize Toxicity and Maximize Benefit to Patients
10天前
已完结
The Retrofit: Lessons From Sotorasib's Dosing Conundrum
10天前
已完结
China’s innovation in translational medicine: rethinking early-stage clinical development
1个月前
已完结
Identification of mutations in circulating cell-free tumour DNA as a biomarker in hepatocellular carcinoma
2个月前
已完结
How Clinical Trial Data Sharing Platforms Can Advance the Study of Biomarkers
3个月前
已完结
Bio-mining for biomarkers with a multi-resolution block chain
3个月前
已完结
A Novel Feature Selection Method for High-Dimensional Mixed Decision Tables
3个月前
已完结
AI-based automation of enrollment criteria and endpoint assessment in clinical trials in liver diseases
3个月前
已完结
Biomarkers as Surrogate Endpoints in Drug Development: Finding Their Right Place
3个月前
已完结
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab–bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study
5个月前
已完结
皖公网安备34019202002308
